On the public citation graph

Simplified Maxwell-Boltzmann-Hansch Function (SMBH function) and its Application in PROTAC

0 signed · 76 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/cbic.202100270openalex-extracted
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
inferredcites →https://doi.org/10.1002/gcc.22935openalex-extracted
PARP inhibitors in ovarian cancer: An overview of the practice‐changing trials
inferredcites →https://doi.org/10.1007/978-3-030-58971-4_1openalex-extracted
Structure, Dynamics and Function of the 26S Proteasome
inferredcites →https://doi.org/10.1007/s00204-023-03562-9openalex-extracted
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
inferredcites →https://doi.org/10.1007/s10637-017-0520-6openalex-extracted
Clinical toxicity of antibody drug conjugates: a meta-analysis of payloads
inferredcites →https://doi.org/10.1007/s40265-017-0752-yopenalex-extracted
Niraparib: First Global Approval
inferredcites →https://doi.org/10.1016/j.annonc.2020.06.004openalex-extracted
The forefront of ovarian cancer therapy: update on PARP inhibitors
inferredcites →https://doi.org/10.1016/j.bbcan.2020.188494openalex-extracted
Effect of probiotics and gut microbiota on anti-cancer drugs: Mechanistic perspectives
inferredcites →https://doi.org/10.1016/j.bioorg.2023.106425openalex-extracted
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
inferredcites →https://doi.org/10.1016/j.bmc.2022.116912openalex-extracted
Discovery of CN0 as a novel proteolysis-targeting chimera (PROTAC) degrader of PARP1 that can activate the cGAS/STING immunity pathway combined with daunorubicin
inferredcites →https://doi.org/10.1016/j.bpc.2021.106662openalex-extracted
Binding free energy calculation of human beta defensin 3 with negatively charged lipid bilayer using free energy perturbation method
inferredcites →https://doi.org/10.1016/j.chembiol.2021.04.011openalex-extracted
Targeted protein degradation: A promise for undruggable proteins
inferredcites →https://doi.org/10.1016/j.ejmech.2021.114094openalex-extracted
Dual-target inhibitors of poly (ADP-ribose) polymerase-1 for cancer therapy: Advances, challenges, and opportunities
inferredcites →https://doi.org/10.1016/j.ejmech.2022.114290openalex-extracted
The state of the art of PROTAC technologies for drug discovery
inferredcites →https://doi.org/10.1016/j.ijrobp.2008.03.046openalex-extracted
A Pilot Safety Study of Lenalidomide and Radiotherapy for Patients With Newly Diagnosed Glioblastoma Multiforme
inferredcites →https://doi.org/10.1016/j.jbc.2021.100647openalex-extracted
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
inferredcites →https://doi.org/10.1016/j.pharmthera.2019.04.008openalex-extracted
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
inferredcites →https://doi.org/10.1016/j.xcrp.2022.101062openalex-extracted
Strategies for the discovery of oral PROTAC degraders aimed at cancer therapy
inferredcites →https://doi.org/10.1016/s0927-7757(01)00628-8openalex-extracted
Reference potentials for adsorption of helium, argon, methane, and krypton in high-silica zeolites
inferredcites →https://doi.org/10.1021/acs.jcim.8b00545openalex-extracted
Comparative Assessment of Scoring Functions: The CASF-2016 Update
inferredcites →https://doi.org/10.1021/acs.jmedchem.1c01532openalex-extracted
Development of BromoTag: A “Bump-and-Hole”–PROTAC System to Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins
inferredcites →https://doi.org/10.1021/acs.jmedchem.3c02124openalex-extracted
Discovery of CBPD-268 as an Exceptionally Potent and Orally Efficacious CBP/p300 PROTAC Degrader Capable of Achieving Tumor Regression
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b00055openalex-extracted
An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
inferredcites →https://doi.org/10.1021/acscentsci.0c00411openalex-extracted
Targeted Degradation of Oncogenic KRAS G12C by VHL-Recruiting PROTACs
inferredcites →https://doi.org/10.1021/acsmedchemlett.9b00597openalex-extracted
PROTAC Technology: Opportunities and Challenges
inferredcites →https://doi.org/10.1021/ci500081mopenalex-extracted
Comparative Assessment of Scoring Functions on an Updated Benchmark: 2. Evaluation Methods and General Results
inferredcites →https://doi.org/10.1021/ci9000053openalex-extracted
Comparative Assessment of Scoring Functions on a Diverse Test Set
inferredcites →https://doi.org/10.1021/ja049281ropenalex-extracted
Development of a Quantum Mechanics-Based Free-Energy Perturbation Method: Use in the Calculation of Relative Solvation Free Energies
inferredcites →https://doi.org/10.1021/jacsau.3c00195openalex-extracted
Uncovering the Kinetic Characteristics and Degradation Preference of PROTAC Systems with Advanced Theoretical Analyses
inferredcites →https://doi.org/10.1021/jp904505wopenalex-extracted
Crystallizations, Solid-State Phase Transformations and Dissolution Behavior Explained by Dispersive Kinetic Models Based on a Maxwell−Boltzmann Distribution of Activation Energies: Theory, Applications, and Practical Limitations
inferredcites →https://doi.org/10.1038/cr.2016.86openalex-extracted
The life cycle of the 26S proteasome: from birth, through regulation and function, and onto its death
inferredcites →https://doi.org/10.1038/nchembio.2329openalex-extracted
Structural basis of PROTAC cooperative recognition for selective protein degradation
inferredcites →https://doi.org/10.1038/s41392-019-0101-6openalex-extracted
PROTACs: great opportunities for academia and industry
inferredcites →https://doi.org/10.1038/s41392-022-00966-4openalex-extracted
Targeted protein degradation: mechanisms, strategies and application
inferredcites →https://doi.org/10.1038/s41408-024-01136-1openalex-extracted
Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
inferredcites →https://doi.org/10.1038/s41467-017-01883-9openalex-extracted
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
inferredcites →https://doi.org/10.1038/s41467-023-39904-5openalex-extracted
Affinity and cooperativity modulate ternary complex formation to drive targeted protein degradation
inferredcites →https://doi.org/10.1038/s41573-021-00371-6openalex-extracted
PROTAC targeted protein degraders: the past is prologue
inferredcites →https://doi.org/10.1038/s41589-019-0379-2openalex-extracted
Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation
inferredcites →https://doi.org/10.1038/s41589-021-00878-4openalex-extracted
Trivalent PROTACs enhance protein degradation via combined avidity and cooperativity
inferredcites →https://doi.org/10.1038/s41589-023-01410-6openalex-extracted
Unraveling the diversity of molecular glue degraders
inferredcites →https://doi.org/10.1038/s41598-019-56177-5openalex-extracted
Disordered region of cereblon is required for efficient degradation by proteolysis-targeting chimera
inferredcites →https://doi.org/10.1038/s41598-020-80769-1openalex-extracted
Automation of absolute protein-ligand binding free energy calculations for docking refinement and compound evaluation
inferredcites →https://doi.org/10.1039/c0mb00074dopenalex-extracted
Impact of linker length on the activity of PROTACs
inferredcites →https://doi.org/10.1039/c3cc38885aopenalex-extracted
Detection of carbohydrates on the surface of cancer and normal cells by topography and recognition imaging
inferredcites →https://doi.org/10.1039/c3cc43779eopenalex-extracted
The force of transporting a single amino acid into the living cell measured using atomic force microscopy
inferredcites →https://doi.org/10.1039/c3nr00553dopenalex-extracted
A single-molecule force spectroscopy study of the interactions between lectins and carbohydrates on cancer and normal cells
inferredcites →https://doi.org/10.1053/j.gastro.2022.10.018openalex-extracted
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
inferredcites →https://doi.org/10.1073/pnas.0707647104openalex-extracted
Mapping hydration dynamics around a protein surface
inferredcites →https://doi.org/10.1080/14796694.2024.2407756openalex-extracted
Cardiac toxicity of HER-2 targeting antibody–drug conjugates: overview and clinical implications
inferredcites →https://doi.org/10.1103/physrevb.51.605openalex-extracted
Momentum distributions in quantum and nearly classical liquids
inferredcites →https://doi.org/10.1103/physreve.47.3145openalex-extracted
Constant-temperature molecular dynamics with momentum conservation
inferredcites →https://doi.org/10.1103/physreve.96.042606openalex-extracted
Direct measurement of the ballistic motion of a freely floating colloid in Newtonian and viscoelastic fluids
inferredcites →https://doi.org/10.1109/tcbb.2012.36openalex-extracted
A Comparative Assessment of Ranking Accuracies of Conventional and Machine-Learning-Based Scoring Functions for Protein-Ligand Binding Affinity Prediction
inferredcites →https://doi.org/10.1111/j.1365-2141.2007.06946.xopenalex-extracted
Should prophylactic granulocyte‐colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide‐based therapy?
inferredcites →https://doi.org/10.1124/dmd.123.001430openalex-extracted
Kinase Inhibitors FDA Approved 2018–2023: Drug Targets, Metabolic Pathways, and Drug-Induced Toxicities
inferredcites →https://doi.org/10.1126/science.1248091openalex-extracted
Observation of Brownian Motion in Liquids at Short Times: Instantaneous Velocity and Memory Loss
inferredcites →https://doi.org/10.1126/science.aam7344openalex-extracted
PARP inhibitors: Synthetic lethality in the clinic
inferredcites →https://doi.org/10.1136/gutjnl-2021-326264openalex-extracted
Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes
inferredcites →https://doi.org/10.1146/annurev-biochem-062917-011931openalex-extracted
Structure and Function of the 26S Proteasome
inferredcites →https://doi.org/10.1146/annurev-med-050913-022545openalex-extracted
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
inferredcites →https://doi.org/10.1158/0008-5472.can-12-2753openalex-extracted
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
inferredcites →https://doi.org/10.1158/1541-7786.mcr-18-0138openalex-extracted
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow
inferredcites →https://doi.org/10.1158/1541-7786.mcr-18-0523openalex-extracted
NF-κB and Poly (ADP-ribose) Polymerase 1 Form a Positive Feedback Loop that Regulates DNA Repair in Acute Myeloid Leukemia Cells
inferredcites →https://doi.org/10.1177/1078155219895066openalex-extracted
PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and cost
inferredcites →https://doi.org/10.1182/blood.2023022993openalex-extracted
Degraders upgraded: the rise of PROTACs in hematological malignancies
inferredcites →https://doi.org/10.1186/s12943-021-01434-3openalex-extracted
Proteolysis-targeting chimeras (PROTACs) in cancer therapy
inferredcites →https://doi.org/10.1186/s13045-022-01310-7openalex-extracted
Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy
inferredcites →https://doi.org/10.1186/s13046-020-01672-1openalex-extracted
Proteolysis targeting chimeras (PROTACs) in cancer therapy
inferredcites →https://doi.org/10.1186/s13321-022-00639-yopenalex-extracted
Predicting the mutation effects of protein–ligand interactions via end-point binding free energy calculations: strategies and analyses
inferredcites →https://doi.org/10.1634/theoncologist.2015-0438openalex-extracted
Clinical Application of Poly(ADP-Ribose) Polymerase Inhibitors in High-Grade Serous Ovarian Cancer
inferredcites →https://doi.org/10.2174/0109298673251030231004052822openalex-extracted
Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor for Treating Relapsed or Refractory Mantle Cell Lymphoma in Adults
inferredcites →https://doi.org/10.3390/cancers15030713openalex-extracted
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
inferredcites →https://doi.org/10.3390/life12010048openalex-extracted
Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile
inferredcites →https://doi.org/10.3390/ph16060802openalex-extracted
Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting
inferredcites →https://doi.org/10.7566/jpsj.86.114602openalex-extracted
Osmotic Suppression of Positional Fluctuation of a Trapped Particle in a Near-Critical Binary Fluid Mixture in the Regime of the Gaussian Model
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.